Literature DB >> 12003823

Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function.

Amanda L Chancey1, Gregory L Brower, Joseph S Janicki.   

Abstract

Mast cells contain proteases capable of activating matrix metalloproteinases (MMPs). However, given the relatively low density of mast cells in the myocardium (i.e., 1.5-5.3 cells/mm(2)), it is unknown whether these enzymes are present in sufficient quantities in the normal heart to mediate MMP activation. Accordingly, this study sought to determine whether chemically induced degranulation of cardiac mast cells (with compound 48/80) would have an effect in isolated, blood-perfused, functioning rat hearts. Mast cell degranulation produced a 15% increase in histamine levels present in the coronary efflux, a significant increase in myocardial water (i.e., edema) relative to normal values (80.1 +/- 3.4% vs. 77.4 +/- 1.08%, P < or = 0.03), a substantial activation of MMP-2 (126% increase relative to controls, P < or = 0.02), and a marked decrease in myocardial collagen volume fraction (0.46 +/- 0.10% vs. 0.97 +/- 0.33%, P < or = 0.001). Furthermore, although an increase in ventricular stiffness was expected due to the extent of edema resulting from mast cell degranulation, modest ventricular dilatation was observed. These findings clearly demonstrate that the number of mast cells present in normal hearts is sufficient to mediate activation of MMPs and produce extracellular matrix degradation, thereby potentially causing subsequent ventricular dilatation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003823     DOI: 10.1152/ajpheart.00777.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  21 in total

Review 1.  The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Jason D Gardner; Amanda L Chancey; James A Stewart
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

Review 2.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

Authors:  Scott P Levick; Giselle C Meléndez; Eric Plante; Jennifer L McLarty; Gregory L Brower; Joseph S Janicki
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

3.  Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure.

Authors:  Gregory L Brower; Scott P Levick; Joseph S Janicki
Journal:  Heart Lung Circ       Date:  2015-03-13       Impact factor: 2.975

4.  Opposing roles of PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in dyslipidemic dilated cardiomyopathy.

Authors:  Chetan P Hans; Yumei Feng; Amarjit S Naura; Dana Troxclair; Mourad Zerfaoui; Danish Siddiqui; Ju Jihang; Hogyoung Kim; Alan D Kaye; Khalid Matrougui; Eric Lazartigues; A Hamid Boulares
Journal:  Cardiovasc Pathol       Date:  2010-05-07       Impact factor: 2.185

5.  Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment.

Authors:  Benjamin L Parker; Giuseppe Palmisano; Alistair V G Edwards; Melanie Y White; Kasper Engholm-Keller; Albert Lee; Nichollas E Scott; Daniel Kolarich; Brett D Hambly; Nicolle H Packer; Martin R Larsen; Stuart J Cordwell
Journal:  Mol Cell Proteomics       Date:  2011-03-25       Impact factor: 5.911

6.  The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Scott P Levick
Journal:  Methods Mol Biol       Date:  2015

Review 7.  Cardiac fibroblast: the renaissance cell.

Authors:  Colby A Souders; Stephanie L K Bowers; Troy A Baudino
Journal:  Circ Res       Date:  2009-12-04       Impact factor: 17.367

8.  Early predictors of cardiac decompensation in experimental volume overload.

Authors:  Christelle Oliver-Dussault; Alexis Ascah; Mariannick Marcil; Jimmy Matas; Sylvie Picard; Philippe Pibarot; Yan Burelle; Christian F Deschepper
Journal:  Mol Cell Biochem       Date:  2010-01-07       Impact factor: 3.396

Review 9.  The immune system and cardiac repair.

Authors:  Nikolaos G Frangogiannis
Journal:  Pharmacol Res       Date:  2008-06-24       Impact factor: 7.658

10.  ETA selective receptor antagonism prevents ventricular remodeling in volume-overloaded rats.

Authors:  David B Murray; Ronald McMillan; Gregory L Brower; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.